Jian Li1, Wen Yun1, Jianwei Qin1, Jianhua Zhao2, Xuemin Liu3, Jianzhong Wu1, Minghua Ji1, Jinhai Tang1. 1. Cancer Hospital of Jiangsu Province, Nanjing Medical University, China. 2. Clinical Laboratory Center of Jiangsu Province, Nanjing, Affiliated Hospital of Zhangjiagang City, Nanjing Medical University, China. 3. Department of General Surgery, Affiliated Hospital of Zhangjiagang City, Nanjing Medical University, China.
Abstract
BACKGROUND: The inflammatory myofibroblastic tumor (IMT) is an uncommon low-risk lesion with only a few cases described in the literature. CASE REPORT: Here, we report a unique case of an IMT coexisting with breast cancer. Modified radical mastectomy was performed, followed by TAC chemotherapy (taxotere, adriamycin and cyclophosphamide). At the 2-year follow-up, the patient continues to be disease free. CONCLUSION: At the preoperative stage, definitive diagnoses of masses are extremely difficult; surgery is advised only after the diagnosis is confirmed by pathological examination.
BACKGROUND: The inflammatory myofibroblastic tumor (IMT) is an uncommon low-risk lesion with only a few cases described in the literature. CASE REPORT: Here, we report a unique case of an IMT coexisting with breast cancer. Modified radical mastectomy was performed, followed by TAC chemotherapy (taxotere, adriamycin and cyclophosphamide). At the 2-year follow-up, the patient continues to be disease free. CONCLUSION: At the preoperative stage, definitive diagnoses of masses are extremely difficult; surgery is advised only after the diagnosis is confirmed by pathological examination.
Entities:
Keywords:
Breast cancer; Inflammatory myofibroblastic tumor
Authors: C Salakos; N M Nikolakopoulou; Y De Verney; A C Tsamandas; T Ziambaras; T Petsas; D A Papanastasiou Journal: Eur J Pediatr Surg Date: 2010-02-22 Impact factor: 2.191